Systematic identification of cardiotoxic e-cigarette flavorants

系统鉴定心脏毒性电子烟香料

基本信息

  • 批准号:
    10451184
  • 负责人:
  • 金额:
    $ 71.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-22 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

Abstract The use of e-cigarettes (e-cigs) has increased substantially since they were first introduced in 2003. E-cig devices aerosolize e-liquids that typically consist of humectants with variable levels of nicotine and flavoring chemicals. Although there are thousands of commercially available flavor mixtures, they routinely overlap in individual flavor chemicals (flavorants), which are far fewer in number. Many of these flavorants belong to common chemical classes and are generally recognized as safe for ingestion. However, their direct and indirect cardiac effects following heating and inhalation, particularly in combination with nicotine, remain mostly unknown. Direct exposure to nicotine alone distinctly affects the cardiac action potential waveform, potentially contributing to the high incidence of arrhythmias and sudden cardiac death among smokers. Recent evidence also suggests that nicotine in e-cigs may similarly promote adverse cardiac outcomes. Yet, the influence of flavorants on the cardiac effects of e-cig aerosols remains untested. In our ongoing work, we found that exposure to nicotine- containing e-cig aerosols of various flavors acutely and differentially altered the electrocardiogram (ECG) in mice, variably inducing QT interval prolongation, increasing heart rate, and evoking arrhythmia. As well, two separate e-liquids with the same characterizing flavorant consistently increased ventricular arrhythmias. Furthermore, we observed in cardiomyocytes that treatment with several flavorants common to e-cigs directly altered contractility, rhythmicity, and action potential duration. Nonetheless, it remains unknown how individual flavorants in e-cig aerosols exert direct or indirect cardiac effects in vivo. Considering the growing popularity of e-cigarettes and the urgent need for studying the in vivo toxicological profile of constituents in these products, we propose to test the hypothesis that e-cigarette flavorants modify the effects of e-cig aerosol exposures on cardiac electrophysiology, leading to arrhythmias and functional remodeling of the heart. To test this, we will systematically identify both acute and long-term effects of flavorant exposure on cardiac electrophysiology using a combination of state-of-the-art in vivo, in vitro, and ex vivo approaches. Specifically, we will: 1) Identify the acute effects of flavored e-cig aerosol inhalation on cardiac electrophysiology in vivo, 2) Examine the direct impact of flavorants on cardiac electrophysiology in vitro and ex vivo, and, 3) Elucidate deleterious impacts of acute and chronic flavorant aerosol exposure on cardiac electrophysiology, structure, and function. These studies, which are responsive to the research priorities of the FDA/CTP, will provide new data showing how different flavor chemicals affect cardiac excitability and potentially promote arrhythmogenesis. Such results would aid in formulating policies regulating the manufacture, distribution and marketing of flavored e-cigarettes.
抽象的 自2003年首次引入电子烟(电子烟)以来,电子烟(电子烟)的使用已大大增加。 设备雾化的电子液体,通常由具有变化水平的尼古丁和调味料的湿润剂组成 化学物质。尽管有成千上万的市售风味混合物,但它们通常重叠 单个风味化学品(味道),数量少得多。这些调味剂中有许多属于 常见的化学类别,通常被认为是安全摄入的安全。但是,他们的直接和间接 加热和吸入后的心脏效应,尤其是与尼古丁联合使用,仍然尚不清楚。 直接暴露于尼古丁会明显影响心脏动作电位波形,并有可能导致 吸烟者的心律不齐和心脏猝死的高发病率。最近的证据也表明 电子烟中的尼古丁可能会类似地促进心脏不良后果。然而,调味剂对 电子烟气溶胶的心脏影响未经测试。在我们正在进行的工作中,我们发现暴露于尼古丁 - 包含各种口味的E-CIG气溶胶急性和差异改变了小鼠的心电图(ECG), 可变诱导QT间隔延长,心率增加并引起心律不齐。同样,两个分开 具有相同特征风味剂的电子液体始终增加心室心律不齐。此外,我们 在心肌细胞中观察到,用电子烟的几种调味剂直接改变收缩力, 节奏性和动作潜在持续时间。尽管如此,尚不清楚e-cig中的个体味道如何 气溶胶在体内发挥直接或间接心脏作用。考虑到电子烟和 迫切需要研究这些产品中成分的体内毒理学特征,我们建议测试 电子烟味剂修改了电子烟气暴露对心脏的影响的假设 电生理学,导致心律不齐和功能重塑。为了测试这一点,我们将 系统地确定风味剂暴露剂对心脏电生理学的急性和长期影响 在体内,体外和体内方法的结合。具体来说,我们将:1)确定 调味的E-cig气溶胶吸入对体内心脏生理学的急性影响,2)检查 调味剂对体外和体内心脏生理学的直接影响,3)阐明有害 急性和慢性风味剂气溶胶暴露对心脏电生理学,结构和 功能。这些研究对FDA/CTP的研究优先级有回应的研究将提供新数据 表明不同风味化学物质如何影响心脏兴奋性并可能促进心律失常。 这样的结果将有助于制定规范调味的制造,分销和营销的政策 电子烟。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Alex Perrow Carll的其他基金

Systematic identification of cardiotoxic e-cigarette flavorants
系统鉴定心脏毒性电子烟香料
  • 批准号:
    10610732
    10610732
  • 财政年份:
    2022
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
The Role of E-cigarette Characteristics and Constituents in Cardiac Dysfunction--Diversity Supplement
电子烟特性和成分在心脏功能障碍中的作用--多样性补充
  • 批准号:
    10005694
    10005694
  • 财政年份:
    2020
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
The Role of E-cigarette Characteristics and Constituents in Cardiac Dysfunction
电子烟的特性和成分在心脏功能障碍中的作用
  • 批准号:
    10160948
    10160948
  • 财政年份:
    2019
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:

相似国自然基金

去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
  • 批准号:
    81900151
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
  • 批准号:
    81870113
  • 批准年份:
    2018
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
  • 批准号:
    81570122
  • 批准年份:
    2015
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
NR3C1基因突变在成人急性淋巴细胞白血病耐药与复发中的作用与机制研究
  • 批准号:
    81470309
  • 批准年份:
    2014
  • 资助金额:
    75.0 万元
  • 项目类别:
    面上项目
儿童和成人急性T淋巴细胞白血病中miRNA和转录因子共调控网络的差异性研究
  • 批准号:
    31270885
  • 批准年份:
    2012
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of Primary Sensory Neuron CaMKII Signaling in Regulation of Pain
初级感觉神经元 CaMKII 信号传导在疼痛调节中的作用
  • 批准号:
    10656886
    10656886
  • 财政年份:
    2023
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
  • 批准号:
    10740796
    10740796
  • 财政年份:
    2023
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
FGF13 Control of Hippocampal Excitability in Cocaine Contextual Memory
FGF13 对可卡因情境记忆中海马兴奋性的控制
  • 批准号:
    10595518
    10595518
  • 财政年份:
    2022
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别:
Dissecting the role of gut microbial-derived metabolites on epilepsy
剖析肠道微生物代谢物对癫痫的作用
  • 批准号:
    10502915
    10502915
  • 财政年份:
    2022
  • 资助金额:
    $ 71.37万
    $ 71.37万
  • 项目类别: